NEOEN And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – NEOEN (NEOEN.PA), SELVAAG BOLIG (SBO.OL), X-FAB (XFAB.PA) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. NEOEN (NEOEN.PA)

48.5% sales growth and 7.39% return on equity

Neoen S.A., an independent renewable energy production company, engages in the development and operation of renewable energy power plants. The company operates through Solar Power, Wind Power, Storage, Farm-Down, Development and Investments, and Eliminations segments. It operates in Argentina, Australia, Canada, Ecuador, the United States, Finland, France, Ireland, Italy, Jamaica, Mexico, Mozambique, Portugal, El Salvador, Sweden, and Zambia. Neoen S.A. was incorporated in 2008 and is headquartered in Paris, France. Neoen S.A. operates as a subsidiary of Impala SAS.

Earnings Per Share

As for profitability, NEOEN has a trailing twelve months EPS of €1.14.

PE Ratio

NEOEN has a trailing twelve months price to earnings ratio of 24.19. Meaning, the purchaser of the share is investing €24.19 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.39%.

Volume

Today’s last reported volume for NEOEN is 51591 which is 65.39% below its average volume of 149083.

Yearly Top and Bottom Value

NEOEN’s stock is valued at €27.58 at 11:20 EST, way below its 52-week high of €36.76 and way above its 52-week low of €23.04.

Sales Growth

NEOEN’s sales growth is 63.4% for the ongoing quarter and 48.5% for the next.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on May 17, 2023, the estimated forward annual dividend rate is 0.13 and the estimated forward annual dividend yield is 0.45%.

More news about NEOEN.

2. SELVAAG BOLIG (SBO.OL)

31.3% sales growth and 8.14% return on equity

Selvaag Bolig ASA, a housing development company, engages in the development, construction, and sale of residential properties in Greater Oslo, Bergen, Stavanger, Trondheim, and Stockholm. The company also offers project management services. Selvaag Bolig ASA was incorporated in 2008 and is headquartered in Oslo, Norway. Selvaag Bolig ASA is a subsidiary of Selvaag AS.

Earnings Per Share

As for profitability, SELVAAG BOLIG has a trailing twelve months EPS of kr1.94.

PE Ratio

SELVAAG BOLIG has a trailing twelve months price to earnings ratio of 16.86. Meaning, the purchaser of the share is investing kr16.86 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.14%.

Yearly Top and Bottom Value

SELVAAG BOLIG’s stock is valued at kr32.70 at 11:20 EST, way below its 52-week high of kr39.85 and way above its 52-week low of kr25.30.

Earnings Before Interest, Taxes, Depreciation, and Amortization

SELVAAG BOLIG’s EBITDA is 135.63.

More news about SELVAAG BOLIG.

3. X-FAB (XFAB.PA)

23.3% sales growth and 19.58% return on equity

X-FAB Silicon Foundries SE operates as an analog/mixed-signal semiconductor technology foundry. The company manufactures silicon wafers for automotive, industrial, consumer, medical, and mobile communications, and other applications; and analog/mixed-signal integrated circuits, sensors, and micro-electro-mechanical systems. It also provides manufacturing and design support services for customers that design analog/mixed-signal integrated circuits and other semiconductor devices, as well as engineering and prototyping, outsourcing, technical, and design support services. The company serves integrated device manufacturers, original equipment manufacturers, and fabless semiconductor companies. It operates in Belgium, Germany, the United Kingdom, Austria, France, Switzerland, Denmark, Sweden, Finland, Netherlands, Ireland, Singapore, China, Japan, Thailand, Malaysia, Korea, Taiwan, Hong Kong, New Zealand, the United States, and internationally. The company was founded in 1992 and is based in Tessenderlo, Belgium.

Earnings Per Share

As for profitability, X-FAB has a trailing twelve months EPS of €1.14.

PE Ratio

X-FAB has a trailing twelve months price to earnings ratio of 8.18. Meaning, the purchaser of the share is investing €8.18 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.58%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 24.1%, now sitting on 852.69M for the twelve trailing months.

More news about X-FAB.

4. NAVAMEDIC (NAVA.OL)

20.7% sales growth and 11.97% return on equity

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.

PE Ratio

NAVAMEDIC has a trailing twelve months price to earnings ratio of 31.36. Meaning, the purchaser of the share is investing kr31.36 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.97%.

Moving Average

NAVAMEDIC’s worth is under its 50-day moving average of kr37.44 and below its 200-day moving average of kr37.55.

More news about NAVAMEDIC.

5. SATS (SATS.OL)

10.1% sales growth and 3.89% return on equity

Sats ASA provides fitness and training services in Norway, Sweden, Denmark, and Finland. The company offers sportswear, fitness gear, bars, and energy drinks. It operates 275 fitness clubs under the SATS, ELIXIA, Fresh Fitness, SATSonline and SATSYoga brands. The company was founded in 1995 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, SATS has a trailing twelve months EPS of kr0.17.

PE Ratio

SATS has a trailing twelve months price to earnings ratio of 101.06. Meaning, the purchaser of the share is investing kr101.06 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.89%.

Yearly Top and Bottom Value

SATS’s stock is valued at kr17.18 at 11:20 EST, below its 52-week high of kr17.74 and way higher than its 52-week low of kr6.30.

Revenue Growth

Year-on-year quarterly revenue growth grew by 14.4%, now sitting on 4.59B for the twelve trailing months.

Moving Average

SATS’s value is way above its 50-day moving average of kr14.14 and way above its 200-day moving average of kr11.55.

More news about SATS.

6. BOUVET (BOUV.OL)

9.7% sales growth and 60.9% return on equity

Bouvet ASA provides IT and digital communication consultancy services for public and private sector companies in Norway, Sweden, and internationally. Bouvet ASA was founded in 1995 and is based in Oslo, Norway.

Earnings Per Share

As for profitability, BOUVET has a trailing twelve months EPS of kr3.15.

PE Ratio

BOUVET has a trailing twelve months price to earnings ratio of 19.59. Meaning, the purchaser of the share is investing kr19.59 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.9%.

Volume

Today’s last reported volume for BOUVET is 12700 which is 61.83% below its average volume of 33280.

Moving Average

BOUVET’s value is under its 50-day moving average of kr63.78 and under its 200-day moving average of kr62.05.

More news about BOUVET.

7. PERNOD RICARD (RI.PA)

7.9% sales growth and 13.85% return on equity

Pernod Ricard SA produces and sells wines and spirits worldwide. The company offers whiskey, vodka, gin, rum, liqueur and bitters, champagne, tequila and mezcal, and aperitif under the brands 100 Pipers, Aberlour, Absolut, Absolut Elyx, Altos, ARARAT, Augier, Avion, Ballantine's, Becherovka, Beefeater, Blenders Pride, Brancott Estate, Campo Viejo, Ceder's, Chivas, Church Road, Clan Campbell, Del Maguey, George Wyndham, Green Spot, Havana Club, Imperial, Imperial Blue, Italicus, J.P. Wiser's, Jacob's Creek, Jameson, Jefferson's, Kahlúa, Kenwood, KI NO BI, Lillet, Long John, L'Orbe, Lot No. 40, Malfy, Malibu, Martell, Method & Madness, Midleton Very Rare, Minttu, Monkey 47, Mumm, Olmeca, Ostoya, Passport Scotch, Pastis 51, Pernod, Perrier-Jouët, Plymouth Gin, Powers, Rabbit Hole, Ramazzotti, Redbreast, Ricard, Royal Salute, Royal Stag, Scapa, Seagram's Gin, Secret Speyside, Smooth Ambler, Something Special, St Hugo, Stoneleigh, Suze, The Glenlivet, TX, Wyborowa, and Ysios. It also provides non-alcoholic beverages under the brands Ceder's, Suze Tonic 0%, Cinzano Spritz 0%, Pacific, Campo Viejo Sparkling 0%, and Jacob's Creek Unvined. Pernod Ricard SA was founded in 1805 and is headquartered in Paris, France.

Earnings Per Share

As for profitability, PERNOD RICARD has a trailing twelve months EPS of €8.8.

PE Ratio

PERNOD RICARD has a trailing twelve months price to earnings ratio of 16.89. Meaning, the purchaser of the share is investing €16.89 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.85%.

More news about PERNOD RICARD.

Leave a Reply

Your email address will not be published. Required fields are marked *